Holen Sie sich die Stockscreener-App
7.96
11.33%
0.81
Handel nachbörslich:
7.88
-0.08
-1.01%
Schlusskurs vom Vortag:
$7.15
Offen:
$7.75
24-Stunden-Volumen:
330.87K
Relative Volume:
3.66
Marktkapitalisierung:
$766.65M
Einnahmen:
$106.66M
Nettoeinkommen (Verlust:
$15.16M
KGV:
85.13
EPS:
0.0935
Netto-Cashflow:
$6.37M
1W Leistung:
+7.42%
1M Leistung:
-2.57%
6M Leistung:
+9.19%
1J Leistung:
-35.70%
1-Tages-Spanne:
$7.75
$8.50
1-Wochen-Bereich:
$7.15
$8.50
52-Wochen-Spanne:
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Firmenname
Gyre Therapeutics Inc
Sektor
Branche
Telefon
(619) 949-3681
Adresse
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Vergleichen Sie GYRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
7.96 | 649.41M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-11 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-04-29 | Fortgesetzt | Stephens | Overweight |
| 2021-02-10 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-21 | Eingeleitet | Raymond James | Outperform |
| 2019-01-04 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-12 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Eingeleitet | Chardan Capital Markets | Buy |
| 2017-06-06 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-06-30 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten
Visual trend scoring systems applied to Gyre Therapeutics Inc.2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
This Aptiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target - Investing.com
Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target By Investing.com - Investing.com UK
Gyre Therapeutics (NASDAQ:GYRE) Earns Sell (D) Rating from Weiss Ratings - MarketBeat
Gyre Therapeutics Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Small Investment Portfolio - earlytimes.in
Can momentum traders help lift Gyre Therapeutics Inc.Weekly Trend Report & Safe Entry Point Identification - newser.com
Gyre Therapeutics Inc. stock outlook for YEARJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com
Volatility clustering patterns for Gyre Therapeutics Inc.Portfolio Value Summary & Short-Term Swing Trade Alerts - newser.com
Real time alert setup for Gyre Therapeutics Inc. performanceTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com
Gyre Therapeutics president Ma Songjiang sells $42,760 in stock - MSN
Discovering 3 Undiscovered Gems In The US Market - simplywall.st
Goldman Sachs Group Inc. Cuts Stock Position in Gyre Therapeutics, Inc. $GYRE - Defense World
Developing predictive dashboards with Gyre Therapeutics Inc. dataPortfolio Performance Report & AI Forecast Swing Trade Picks - newser.com
What analysts say about Gyre Therapeutics Inc stockStock Valuation Metrics & Free Quantitative Trading Strategies - earlytimes.in
Gyre Therapeutics president sells $45,380 in stock - MSN
Is Gyre Therapeutics Inc a good long term investmentEarnings Forecast Updates & Free Dynamic Capital Growth - earlytimes.in
Financial Survey: Theratechnologies (NASDAQ:THTX) vs. Gyre Therapeutics (NASDAQ:GYRE) - Defense World
Does Gyre Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Fed Impact & Stock Portfolio Risk Management - newser.com
Gyre Therapeutics, Inc.(NasdaqCM: GYRE) added to S&P Global BMI Index - MarketScreener
Growth Review: Is Gyre Therapeutics Inc stock a value trapJobs Report & Short-Term High Return Ideas - خودرو بانک
Is Gyre Therapeutics Inc currently under institutional pressure2025 AllTime Highs & Risk Controlled Stock Pick Alerts - خودرو بانک
US Market Wrap: Will Gyre Therapeutics Inc stock hit new highs in YEARJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - خودرو بانک
Aug Final Week: Is Gyre Therapeutics Inc stock showing strong momentumTrade Exit Summary & Community Consensus Stock Picks - خودرو بانک
Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Gyre Therapeutics Inc-Aktie (GYRE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ma Songjiang | President |
May 28 '25 |
Sale |
10.07 |
558 |
5,619 |
2,806,084 |
| Ma Songjiang | President |
May 22 '25 |
Sale |
10.97 |
2,000 |
21,940 |
2,808,824 |
| Ma Songjiang | President |
May 23 '25 |
Sale |
10.24 |
182 |
1,864 |
2,808,642 |
| Ma Songjiang | President |
May 20 '25 |
Sale |
11.25 |
2,000 |
22,500 |
2,812,824 |
| Ma Songjiang | President |
May 21 '25 |
Sale |
10.83 |
2,000 |
21,660 |
2,810,824 |
| Ma Songjiang | President |
May 16 '25 |
Sale |
11.31 |
2,000 |
22,620 |
2,816,824 |
| Ma Songjiang | President |
May 19 '25 |
Sale |
11.11 |
2,000 |
22,220 |
2,814,824 |
| Ma Songjiang | President |
May 15 '25 |
Sale |
10.68 |
2,000 |
21,360 |
2,818,824 |
| Ma Songjiang | President |
May 14 '25 |
Sale |
11.30 |
20 |
226 |
2,820,824 |
| Ye Weiguo | Chief Operating Officer |
Apr 01 '25 |
Option Exercise |
0.75 |
50,000 |
37,500 |
700,000 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):